For: |
Smith SM, O’Morain C, McNamara D. Antimicrobial susceptibility testing for |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/9912.htm |
Number | Citing Articles |
1 |
Miguel Gallardo Padilla, José Luis León Falconi, Rafael Sánchez-Nebreda Arias, Carmen Gómez Santos, María del Carmen Muñoz Egea, Enrique la Orden Izquierdo. Impact of the use of molecular techniques (PCR) on detection and eradication success against Helicobacter pylori. Anales de Pediatría (English Edition) 2022; 96(3): 190 doi: 10.1016/j.anpede.2022.02.001
|
2 |
Ming-Ming Xu, Junfei Zhou, Liping Zeng, Jingchen Xu, Monday M. Onakpa, Jin-Ao Duan, Chun-Tao Che, Hongkai Bi, Ming Zhao. Pimarane-derived diterpenoids with anti-Helicobacter pylori activity from the tuber of Icacina trichantha. Organic Chemistry Frontiers 2021; 8(12): 3014 doi: 10.1039/D1QO00374G
|
3 |
Denise E Brennan, Joseph Omorogbe, Mary Hussey, Donal Tighe, Grainne Holleran, Colm O’Morain, Sinéad M Smith, Deirdre McNamara. Molecular detection of <i>Helicobacter pylori</i> antibiotic resistance in stool <i>vs</i> biopsy samples. World Journal of Gastroenterology 2016; 22(41): 9214-9221 doi: 10.3748/wjg.v22.i41.9214
|
4 |
Burcu Güven, Fulya Gülerman, Birgül Kaçmaz. Helicobacter pyloriresistance to clarithromycin and fluoroquinolones in a pediatric population in Turkey: A cross‐sectional study. Helicobacter 2019; 24(3): e12581 doi: 10.1111/hel.12581
|
5 |
Sang Yoon Kim, Jae Myung Park, Chul-Hyun Lim, Hye Ah Lee, Ga-Yeong Shin, Younghee Choe, Yu Kyung Cho, Myung-Gyu Choi. Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori. Gut and Liver 2021; 15(4): 528 doi: 10.5009/gnl20225
|
6 |
Miguel Gallardo Padilla, José Luis León Falconi, Rafael Sánchez-Nebreda Arias, Carmen Gómez Santos, María del Carmen Muñoz Egea, Enrique la Orden Izquierdo. Impacto del uso de las técnicas moleculares (PCR) en la detección y el éxito erradicador frente a Helicobacter pylori. Anales de Pediatría 2022; 96(3): 190 doi: 10.1016/j.anpedi.2020.11.016
|
7 |
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
|
8 |
Carolina A. Serrano, Miguel A. Leon, Camila Palma, Macarena Vera, Caroll Hernandez, Paul R. Harris. Helicobacter pylori-Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country. Journal of Pediatric Gastroenterology & Nutrition 2017; 64(3): e56 doi: 10.1097/MPG.0000000000001257
|
9 |
Nazlı Arslan, Özlem Yılmaz, Ebru Demiray-Gürbüz. Importance of antimicrobial susceptibility testing for the management of eradication in <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2017; 23(16): 2854-2869 doi: 10.3748/wjg.v23.i16.2854
|
10 |
Muhammad Arif, Quan-Jiang Dong, Mazhar Ali Raja, Shah Zeenat, Zhe Chi, Chen-Guang Liu. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori. Materials Science and Engineering: C 2018; 83: 17 doi: 10.1016/j.msec.2017.08.038
|
11 |
Tiago Gomes da Silva Benigno, Howard Lopes Ribeiro Junior, Orleâncio Gomes Ripardo de Azevedo, Ronald Feitosa Pinheiro, Roberta Taiane Germano de Oliveira, Felipe Silva Maciel, Edson Luiz de Oliveira, Dulciene Maria Magalhães Queiroz, Lucia Libanez Bessa Campelo Braga. Clarithromycin-resistant H. pylori primary strains and virulence genotypes in the Northeastern region of Brazil. Revista do Instituto de Medicina Tropical de São Paulo 2022; 64 doi: 10.1590/s1678-9946202264047
|
12 |
William D Chey, Grigorios I Leontiadis, Colin W Howden, Steven F Moss. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2017; 112(2): 212 doi: 10.1038/ajg.2016.563
|
13 |
Amin Talebi Bezmin Abadi, Yoshio Yamaoka. Helicobacter pylori therapy and clinical perspective. Journal of Global Antimicrobial Resistance 2018; 14: 111 doi: 10.1016/j.jgar.2018.03.005
|
14 |
Young Min Kim, Kyoung Hwa Lee, Jie-Hyun Kim, Soon Young Park, Young Goo Song, Se Yeon Jeon, Hyojin Park. Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?. Antibiotics 2020; 9(9): 589 doi: 10.3390/antibiotics9090589
|
15 |
Nusrat Noor Tanni, Sharmeen Ahmed, Shaheda Anwar, Saifa Kismat, Kakali Halder, Maherun Nesa, Farjana Binte Habib. Endoscopic and histopathological findings in adult dyspeptic patients, and their association with Helicobacter pylori infection in Dhaka, Bangladesh. IJID Regions 2022; 2: 30 doi: 10.1016/j.ijregi.2021.11.006
|
16 |
Jia Di, Jun Zhang, Lei Cao, Ting-ting Huang, Jun-xia Zhang, Yan-ni Mi, Xue Xiao, Ping-ping Yan, Man-li Wu, Tong Yao, Dong-zheng Liu, Jing Liu, Yong-xiao Cao.
Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori
In Vitro
and
In Vivo
. Antimicrobial Agents and Chemotherapy 2020; 64(5) doi: 10.1128/AAC.02192-19
|
17 |
Yonglin Li, Rixu Lin, Yin Jin, Shuqing Jin, Bicheng Chen, Xiuling Wu. Genotyping Helicobacter pylori antibiotic resistance and virulence-associated genes in patients with gastric cancer in Wenzhou, China. Arab Journal of Gastroenterology 2021; 22(4): 267 doi: 10.1016/j.ajg.2021.05.017
|
18 |
Yuri Costa Farago FERNANDES, Gabriel da Rocha BONATTO, Mauro Willeman BONATTO. RECURRENCE RATE OF HELICOBACTER PYLORI IN PATIENTS WITH PEPTIC ULCER FIVE YEARS OR MORE AFTER SUCCESSFUL ERADICATION. Arquivos de Gastroenterologia 2016; 53(3): 152 doi: 10.1590/S0004-28032016000300006
|
19 |
Enzo Ierardi, Floriana Giorgio, Andrea Iannone, Giuseppe Losurdo, Mariabeatrice Principi, Michele Barone, Antonio Pisani, Alfredo Di Leo. Noninvasive molecular analysis of <i>Helicobacter pylori</i>: Is it time for tailored first-line therapy?. World Journal of Gastroenterology 2017; 23(14): 2453-2458 doi: 10.3748/wjg.v23.i14.2453
|
20 |
Kichul Yoon, Nayoung Kim, Jung Won Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Annual eradication rate of bismuth‐containing quadruple therapy as second‐line treatment forHelicobacter pyloriinfection: A 15‐year prospective study at a tertiary hospital in Korea. Helicobacter 2020; 25(3) doi: 10.1111/hel.12685
|
21 |
Rita Matos, Chloë De Witte, Annemieke Smet, Helena Berlamont, Sofie De Bruyckere, Irina Amorim, Fátima Gärtner, Freddy Haesebrouck. Antimicrobial Susceptibility Pattern of Helicobacter heilmannii and Helicobacter ailurogastricus Isolates. Microorganisms 2020; 8(6): 957 doi: 10.3390/microorganisms8060957
|
22 |
Richard J Hackett, Sean L Preston.
H.pylori,
part
II
: management in an era of antibiotic resistance
. Trends in Urology & Men's Health 2021; 12(5): 18 doi: 10.1002/tre.818
|
23 |
B. Bluemel, H. Goelz, B. Goldmann, J. Grüger, H. Hamel, K. Loley, T. Ludolph, J. Meyer, S. Miehlke, A. Mohr, K. Tüffers, H. Usadel, S. Wagner, H. Wenzel, L. Wiemer, J. Vorreiter, B. Eisele, D. Hofreuter, E.-O. Glocker. Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018. Clinical Microbiology and Infection 2020; 26(2): 235 doi: 10.1016/j.cmi.2019.06.007
|
24 |
You-hua Wang, Zhi-fa Lv, Yao Zhong, Dong-sheng Liu, Shu-ping Chen, Yong Xie. The internalization ofHelicobacter pyloriplays a role in the failure ofH. pylorieradication. Helicobacter 2017; 22(1): e12324 doi: 10.1111/hel.12324
|
25 |
Sandra Salillas, Miriam Alías, Valérie Michel, Alejandro Mahía, Ainhoa Lucía, Liliana Rodrigues, Jessica Bueno, Juan José Galano-Frutos, Hilde De Reuse, Adrián Velázquez-Campoy, José Alberto Carrodeguas, Carlos Sostres, Javier Castillo, José Antonio Aínsa, María Dolores Díaz-de-Villegas, Ángel Lanas, Eliette Touati, Javier Sancho. Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice. Journal of Medicinal Chemistry 2019; 62(13): 6102 doi: 10.1021/acs.jmedchem.9b00355
|
26 |
Gattu Sampath, Muthusamy Govarthanan, Sridharan Krishnamurthy, Prabhusaran Nagarajan, Neelamegam Rameshkumar, Muthukalingan Krishnan, Kayalvizhi Nagarajan. Isolation and identification of metronidazole resistance Helicobacter pylori from gastric patients in the southeastern region of India and its advanced antibacterial treatment using biological silver oxide nanoparticles. Biochemical Engineering Journal 2022; 187: 108445 doi: 10.1016/j.bej.2022.108445
|
27 |
Judit Alarcón-Millán, Gloria Fernández-Tilapa, Enoc Mariano Cortés-Malagón, Carlos Alberto Castañón-Sánchez, José De Sampedro-Reyes, Iván Cruz-del Carmen, Reyes Betancourt-Linares, Adolfo Román-Román. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. Infection, Genetics and Evolution 2016; 44: 190 doi: 10.1016/j.meegid.2016.06.044
|
28 |
Yanmei Zhang, Shiwen Wang, Binjie Hu, Fuju Zhao, Ping Xiang, Danian Ji, Fei Chen, Xiaoli Liu, Feng Yang, Yong Wu, Mimi Kong, Li Nan, Yingxin Miao, Wenrong Jiang, Yi Fang, Jinghao Zhang, Zhijun Bao, Michal A Olszewski, Hu Zhao. Direct detection of Helicobacter pylori in biopsy specimens using a high-throughput multiple genetic detection system. Future Microbiology 2016; 11(12): 1521 doi: 10.2217/fmb-2016-0149
|
29 |
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik. Current Status of the Third-LineHelicobacter pyloriEradication. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6523653
|
30 |
Nuzhat Qureshi, Ping Li, Qing Gu. Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?. Applied Microbiology and Biotechnology 2019; 103(4): 1573 doi: 10.1007/s00253-018-09580-3
|
31 |
Behnam Kalali, Luca Formichella, Markus Gerhard. Diagnosis of Helicobacter pylori: Changes towards the Future. Diseases 2015; 3(3): 122 doi: 10.3390/diseases3030122
|
32 |
Rana B. Haider, Denise E. Brennan, Joseph Omorogbe, Grainne Holleran, Barry Hall, Colm O’Morain, Niall Breslin, Humphrey J. O’Connor, Sinead M. Smith, Deirdre McNamara. A randomized–controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1265 doi: 10.1097/MEG.0000000000000457
|
33 |
Shigenobu Matsuzaki, Jumpei Uchiyama, Iyo Takemura-Uchiyama, Takako Ujihara, Masanori Daibata. Bacteriophage Therapy. Methods in Molecular Biology 2018; 1693: 3 doi: 10.1007/978-1-4939-7395-8_1
|
34 |
Jung Wook Lee, Su Jin Kim, Cheol Woong Choi, Hyeong Jin Kim, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Hyeong Seok Nam, Dae Gon Ryu. Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation. Medicine 2021; 100(21): e26133 doi: 10.1097/MD.0000000000026133
|
35 |
Skander Hathroubi, Stephanie L. Servetas, Ian Windham, D. Scott Merrell, Karen M. Ottemann. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis. Microbiology and Molecular Biology Reviews 2018; 82(2) doi: 10.1128/MMBR.00001-18
|
36 |
Osama Siddique, Anais Ovalle, Ayesha S. Siddique, Steven F. Moss. Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance. The American Journal of Medicine 2018; 131(5): 473 doi: 10.1016/j.amjmed.2017.12.024
|
37 |
Su Jin Kim, Sam Ryong Jee, Moo In Park, Kyoungwon Jung, Gwang Ha Kim, Moon Won Lee, Jin Lee, Jin Seok Jang, Myeongseok Koh. A randomized controlled trial to compare Helicobacter pylori eradication rates between the empirical concomitant therapy and tailored therapy based on 23S rRNA point mutations. Medicine 2022; 101(33): e30069 doi: 10.1097/MD.0000000000030069
|
38 |
Yao-Kuang Wang, Fu-Chen Kuo, Chung-Jung Liu, Meng-Chieh Wu, Hsiang-Yao Shih, Sophie SW Wang, Jeng-Yih Wu, Chao-Hung Kuo, Yao-Kang Huang, Deng-Chyang Wu. Diagnosis of <italic>Helicobacter pylori</italic> infection: Current options and developments. World Journal of Gastroenterology 2015; 21(40): 11221-11235 doi: 10.3748/wjg.v21.i40.11221
|
39 |
Xiao-Min Liao, Gao-Hui Nong, Mei-Zu Chen, Xue-Ping Huang, Yun-Yan Cong, Yi-Ying Huang, Bai-He Wu, Jin-Qi Wei. Modified sequential therapy <italic>vs</italic> quadruple therapy as initial therapy in patients with <italic>Helicobacter</italic> infection. World Journal of Gastroenterology 2015; 21(20): 6310-6316 doi: 10.3748/wjg.v21.i20.6310
|
40 |
Zi-Wei Jing, Yi-Yang Jia, Ning Wan, Min Luo, Meng-Lei Huan, Tai-Bin Kang, Si-Yuan Zhou, Bang-Le Zhang. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials 2016; 84: 276 doi: 10.1016/j.biomaterials.2016.01.045
|
41 |
H. Berlamont, A. Smet, S. De Bruykere, F. Boyen, R. Ducatelle, F. Haesebrouck, C. De Witte. Antimicrobial susceptibility pattern of Helicobacter suis isolates from pigs and macaques. Veterinary Microbiology 2019; 239: 108459 doi: 10.1016/j.vetmic.2019.108459
|
42 |
Wen Zhong Liu, Yong Xie, Hong Lu, Hong Cheng, Zhi Rong Zeng, Li Ya Zhou, Ye Chen, Jiang Bin Wang, Yi Qi Du, Nong Hua Lu. Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection. Helicobacter 2018; 23(2): e12475 doi: 10.1111/hel.12475
|
43 |
Izabela Korona-Glowniak, Halina Cichoz-Lach, Radoslaw Siwiec, Sylwia Andrzejczuk, Andrzej Glowniak, Przemyslaw Matras, Anna Malm. Antibiotic Resistance and Genotypes of Helicobacter pylori Strains in Patients with Gastroduodenal Disease in Southeast Poland. Journal of Clinical Medicine 2019; 8(7): 1071 doi: 10.3390/jcm8071071
|
44 |
Chen Shaofang, Liang Huiqing, Chen Shaodong, Huang Yanping, Wan Shichuan, Huang Yanxia. Effect of Banxia Xiexin decoction on Helicobacter pylori-related peptic ulcers and its possible mechanism via the TGF-β/Smad signaling pathway. Journal of Traditional Chinese Medicine 2018; 38(3): 419 doi: 10.1016/S0254-6272(18)30633-2
|
45 |
Behtash G. Nezami, Mehul Jani, David Alouani, Daniel D. Rhoads, Navid Sadri, Andrew B. Onderdonk. Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment Failure. Journal of Clinical Microbiology 2019; 57(7) doi: 10.1128/JCM.01834-18
|
46 |
Sinead Smith, Breida Boyle, Denise Brennan, Martin Buckley, Paul Crotty, Maeve Doyle, Richard Farrell, Mary Hussey, David Kevans, Peter Malfertheiner, Francis Megraud, Sean Nugent, Anthony O’Connor, Colm O’Morain, Shiobhan Weston, Deirdre McNamara. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. European Journal of Gastroenterology & Hepatology 2017; 29(5): 552 doi: 10.1097/MEG.0000000000000822
|
47 |
Anna Ingibjorg Gunnarsdottir, Hallgrimur Gudjonsson, Hjordis Hardardottir, Karen Drofn Jonsdottir, Einar Stefan Bjornsson. Antibiotic susceptibility of Helicobacter pylori in Iceland. Infectious Diseases 2017; 49(9): 647 doi: 10.1080/23744235.2017.1317359
|
48 |
Gebremicheal Gebreslassie Kasahun, Gebre Teklemariam Demoz, Desilu Mahari Desta. <p>Primary Resistance Pattern of <em>Helicobacter pylori</em> to Antibiotics in Adult Population: A Systematic Review</p>. Infection and Drug Resistance 2020; : 1567 doi: 10.2147/IDR.S250200
|
49 |
Neda Jam, Reza Hajimohammadi, Parvin Gharbani, Ali Mehrizad, Abadi Kahsu Gebre. Evaluation of Antibacterial Activity of Aqueous, Ethanolic and Methanolic Extracts of Areca Nut Fruit on Selected Bacteria. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6663399
|
50 |
Najmeh Salehi, Bahareh Attaran, Negin Eskini, Maryam Esmaeili, Atefeh Sharifirad, Mehdi Sadeghi, Marjan Mohammadi. New insights into resistance ofHelicobacter pyloriagainst third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations. Helicobacter 2019; 24(5) doi: 10.1111/hel.12628
|
51 |
Konrad Egli, Karoline Wagner, Peter M Keller, Lorenz Risch, Martin Risch, Thomas Bodmer. Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.596371
|
52 |
Dejan Stojković, Marina Kostić, Marija Smiljković, Milena Aleksić, Perica Vasiljević, Miloš Nikolić, Marina Soković. Linking Antimicrobial Potential of Natural Products Derived from Aquatic Organisms and Microbes Involved in Alzheimer’s Disease - A Review. Current Medicinal Chemistry 2020; 27(26): 4372 doi: 10.2174/0929867325666180309103645
|
53 |
Loan Thi Thuy Le, Tuan Anh Nguyen, Nghia An Nguyen, Yen Thi Hai Nguyen, Hai Thi Be Nguyen, Liem Thanh Nguyen, Mai Tuyet Vi, Thang Nguyen. Antibiotic Resistance of Helicobacter pylori in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam. Healthcare 2022; 10(6): 1121 doi: 10.3390/healthcare10061121
|
54 |
Denise E Brennan, Colin Dowd, Colm O’Morain, Deirdre McNamara, Sinéad M Smith. Can bacterial virulence factors predict antibiotic resistant <i>Helicobacter pylori</i> infection?. World Journal of Gastroenterology 2018; 24(9): 971-981 doi: 10.3748/wjg.v24.i9.971
|
55 |
Ratha-korn Vilaichone, Natsuda Aumpan, Thawee Ratanachu-ek, Tomohisa Uchida, Lotay Tshering, Varocha Mahachai, Yoshio Yamaoka. Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan. International Journal of Infectious Diseases 2020; 97: 102 doi: 10.1016/j.ijid.2020.05.077
|
56 |
Evariste Tshibangu-Kabamba, Yoshio Yamaoka. Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications. Nature Reviews Gastroenterology & Hepatology 2021; 18(9): 613 doi: 10.1038/s41575-021-00449-x
|
57 |
Darren M. Griffith, Hongyan Li, Melissa V. Werrett, Philip C. Andrews, Hongzhe Sun. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles. Chemical Society Reviews 2021; 50(21): 12037 doi: 10.1039/D0CS00031K
|
58 |
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Neng-Sheng Chu, Pei-Yun Tsai, Ping-I Hsu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Fang-Jung Yu, Chao-Hung Kuo. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. Journal of the Formosan Medical Association 2022; 121(8): 1450 doi: 10.1016/j.jfma.2021.10.011
|
59 |
Yingchao Sun, Lei Yue, Weiling Hu. Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials. European Journal of Clinical Pharmacology 2023; 79(2): 279 doi: 10.1007/s00228-022-03430-y
|
60 |
Natalie Amar, Avi Peretz, Yoram Gerchman. A cheap, simple high throughput method for screening native Helicobacter pylori urease inhibitors using a recombinant Escherichia coli , its validation and demonstration of Pistacia atlantica methanolic extract effectivity and specificity. Journal of Microbiological Methods 2017; 133: 40 doi: 10.1016/j.mimet.2016.11.022
|
61 |
Denise Brennan, Colm O’Morain, Deirdre McNamara, Sinéad M. Smith. Helicobacter Pylori. Methods in Molecular Biology 2021; 2283: 29 doi: 10.1007/978-1-0716-1302-3_4
|
62 |
Mara Di Giulio, Emanuela Di Campli, Soraya Di Bartolomeo, Valentina Cataldi, Leonardo Marzio, Laurino Grossi, Antonio Francesco Ciccaglione, Antonia Nostro, Luigina Cellini. In vitroantimicrobial susceptibility ofHelicobacter pylorito nine antibiotics currently used in Central Italy. Scandinavian Journal of Gastroenterology 2016; 51(3): 263 doi: 10.3109/00365521.2015.1092577
|
63 |
Sinéad M. Smith, Michael Freeley, Paul N. Moynagh, Dermot P. Kelleher. Differential modulation ofHelicobacter pylorilipopolysaccharide-mediated TLR2 signaling by individual Pellino proteins. Helicobacter 2017; 22(1): e12325 doi: 10.1111/hel.12325
|
64 |
Yeon-Ji Kim, Woo Chul Chung. Eradication Therapy for Helicobacter pylori with Diagnostic Test for Clarithromycin Resistance. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019; 19(4): 225 doi: 10.7704/kjhugr.2019.0019
|
65 |
Mohamed Metwally, Raghda Ragab, Hasnaa S Abdel Hamid, Nashwa Emara, Hany Elkholy. Helicobacter pylori Antibiotic Resistance in Egypt: A Single-Center Study. Infection and Drug Resistance 2022; : 5905 doi: 10.2147/IDR.S386082
|
66 |
Sinéad M. Smith, Colm O’Morain, Deirdre McNamara. Helicobacter pylori resistance to current therapies. Current Opinion in Gastroenterology 2019; 35(1): 6 doi: 10.1097/MOG.0000000000000497
|
67 |
Runming Wang, Hongyan Li, Tiffany Ka-Yan Ip, Hongzhe Sun. Medicinal Chemistry. Advances in Inorganic Chemistry 2020; 75: 183 doi: 10.1016/bs.adioch.2019.10.011
|
68 |
Hong Li, Yalin Shen, Xiaona Song, Xiaoqiong Tang, Renwei Hu, Barry James Marshall, Hong Tang, Mohammed Benghezal.
Need for standardization and harmonization of
Helicobacter pylori
antimicrobial susceptibility testing
. Helicobacter 2022; 27(2) doi: 10.1111/hel.12873
|
69 |
Abdul Rehman. InsideHelicobacter pylori: A Serious Threat to Humans. Avicenna Journal of Clinical Microbiology and Infection 2018; 5(1): 60463 doi: 10.5812/ajcmi.60463
|
70 |
Binjie Hu, Fuju Zhao, Shiwen Wang, Michal A Olszewski, Haipeng Bian, Yong Wu, Mimi Kong, Lingli Xu, Yingxin Miao, Yi Fang, Changqing Yang, Hu Zhao, Yanmei Zhang. A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis. Future Microbiology 2016; 11(10): 1261 doi: 10.2217/fmb-2016-0023
|
71 |
Chrysoula (Chrysa) Voidarou, Georgios Rozos, Athanasios Alexopoulos, Stavros Plessas, Ioanna Mantzourani, Elisavet Stavropoulou, Athina Tzora, Eugenia Bezirtzoglou. In Vitro Screening Potential Antibacterial Properties of the Greek Oregano Honey against Clinical Isolates of Helicobacter pylori. Foods 2021; 10(7): 1568 doi: 10.3390/foods10071568
|
72 |
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Sun Min Lee, Choi Soo In, Jung Mogg Kim, Dong Ho Lee. Risk factors of rescue bismuth quadruple therapy failure forHelicobacter pylorieradication. Journal of Gastroenterology and Hepatology 2019; 34(4): 666 doi: 10.1111/jgh.14625
|
73 |
Liya Zhou, Jianzhong Zhang, Zhiqiang Song, Lihua He, Yanqing Li, Jiaming Qian, Peng Bai, Yan Xue, Ye Wang, Sanren Lin. Tailored versus Triple plus Bismuth or Concomitant Therapy as InitialHelicobacter pyloriTreatment: A Randomized Trial. Helicobacter 2016; 21(2): 91 doi: 10.1111/hel.12242
|
74 |
Samantha Flores-Treviño, Soraya Mendoza-Olazarán, Paola Bocanegra-Ibarias, Héctor Jesús Maldonado-Garza, Elvira Garza-González. Helicobacter pyloridrug resistance: therapy changes and challenges. Expert Review of Gastroenterology & Hepatology 2018; 12(8): 819 doi: 10.1080/17474124.2018.1496017
|
75 |
Boram Cha, Byoung Wook Bang, Jong Beom Shin, Eun Jung Ko, Weonjin Ko, Kye Sook Kwon, Yong Woon Shin, Young Ju Suh, Hyungkil Kim. Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area. Scandinavian Journal of Gastroenterology 2021; 56(9): 1017 doi: 10.1080/00365521.2021.1948606
|
76 |
Tai-Cherng Liou, Po-Hao Liao, Yu-Chun Lin, Cheng-Hsin Chu, Shou-Chuan Shih. Intraluminal therapy for Helicobacter pylori
infection. Journal of Gastroenterology and Hepatology 2019; 34(8): 1337 doi: 10.1111/jgh.14627
|
77 |
Xueping Huang, Yuan Liu, Zhihui Lin, Baihe Wu, Gaohui Nong, Yushan Chen, Yuping Lu, Xinhua Ji, Xiang Zhou, Biao Suo, Qiuzhao Chen, Jinqi Wei, Muhammad Hussnain Siddique. Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China. PLOS ONE 2021; 16(9): e0256225 doi: 10.1371/journal.pone.0256225
|
78 |
Shu Kiyotoki, Jun Nishikawa, Isao Sakaida. Efficacy of Vonoprazan for <i>Helicobacter pylori</i> Eradication. Internal Medicine 2020; 59(2): 153 doi: 10.2169/internalmedicine.2521-18
|
79 |
Efrat Broide, Haim Shirin. Evaluation of Exalenz Bioscience’s BreathID forHelicobacter pyloridetection. Expert Review of Molecular Diagnostics 2015; 15(3): 299 doi: 10.1586/14737159.2015.982537
|
80 |
Denish Calmax Angol, Ponsiano Ocama, Tess Ayazika Kirabo, Alfred Okeng, Irene Najjingo, Freddie Bwanga. Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5430723
|
81 |
J. Homolak, M. Nikolić, D. Potoč, M. Živković, D. Bakula, I. Budimir, I. Pavić, D. Hrabar, N. Ljubičić, D. Vražić. The onset of ulcerative colitis upon Helicobacter pylori eradication in a 72-year-old woman: report of a rare case with a 3-year follow-up. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01876-5
|
82 |
Ebrahim Kouhsari, Nourkhoda Sadeghifard, Arezoo Khadiv, Hojjat Sayadi, Taghi Amiriani, Sobhan Ghafourian, Hassan Valadbeigi, Marcela Krutova. Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials 2022; 21(1) doi: 10.1186/s12941-022-00509-3
|
83 |
Yanmei Zhang, Fuju Zhao, Mimi Kong, Shiwen Wang, Li Nan, Binjie Hu, Michal A. Olszewski, Yingxin Miao, Danian Ji, Wenrong Jiang, Yi Fang, Jinghao Zhang, Fei Chen, Ping Xiang, Yong Wu, Hu Zhao. Validation of a High-Throughput Multiplex Genetic Detection System for Helicobacter pylori Identification, Quantification, Virulence, and Resistance Analysis. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01401
|
84 |
Silvia Fernandez-Perez, Gilberto Velazco, Joanna M Lenik, Yvette Achuo-Egbe, Jennifer Harley . Helicobacter pylori Resistance to Triple Therapy in a Multicultural Population in New York City. Cureus 2021; doi: 10.7759/cureus.19883
|
85 |
Mingming Xu, Junfei Zhou, Ding Heng, Xiaorong Su, Monday M. Onakpa, Yuefan Bai, Jin-Ao Duan, Chun-Tao Che, Hongkai Bi, Ming Zhao. Quinone Derivatives as Promising Anti-Helicobacter pylori Agents from Aerial Parts of Mitracarpus hirtus. Journal of Natural Products 2022; 85(4): 1029 doi: 10.1021/acs.jnatprod.1c01163
|